Dr. Vega: Great presentation. Hope you have fun at the meeting.One of the problems with the use of antibodies is that if they are highly selective, one runs into the risk of not detecting even if the epitope is slightly altered. As this is only a case study, would you like to expect to run into this problem? Of course, one could less selective antibodies but then one would not be able to distinguish between different classes of cancers.
Fri Dec 4